Is correction for metallic artefacts mandatory in cardiac SPECT/CT imaging in the presence of pacemaker and implantable cardioverter defibrillator leads?

被引:0
|
作者
Etemadi, Zahra [1 ,2 ,3 ]
Ghafarian, Pardis [4 ,5 ]
Bitarafan-Rajabi, Ahmad [6 ]
Malek, Hadi [6 ]
Rahmim, Arman [7 ,8 ]
Ay, Mohammad Reza [2 ,3 ]
机构
[1] Shiraz Univ Med Sci, Namazi Teaching Hosp, Nucl Med & Mol Imaging Res Ctr, Shiraz, Iran
[2] Univ Tehran Med Sci, Res Ctr Mol & Cellular Imaging, Tehran, Iran
[3] Univ Tehran Med Sci, Dept Med Phys & Biomed Engn, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Chron Resp Dis Res Ctr, Tehran, Iran
[5] Shahid Beheshti Univ Med Sci, Masih Daneshvari Hosp, PET CT & Cyclotron Ctr, Tehran, Iran
[6] Iran Univ Med Sci, Rajaei Cardiovasc Med & Res Ctr, Dept Nucl Med, Cardiovasc Intervent Res Ctr, Tehran, Iran
[7] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA
[8] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA
来源
IRANIAN JOURNAL OF NUCLEAR MEDICINE | 2018年 / 26卷 / 01期
关键词
Cardiac SPECT/CT; Metal artifact reduction; Virtual sonogram; Pacemaker; ICD;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: Metallic artifacts due to pacemaker/implantable cardioverter defibrillator (ICD) leads in CT images can produce artifactual uptake in cardiac SPECT/CT images. The aim of this study was to determine the influence of the metallic artifacts due to pacemaker and ICD leads on myocardial SPECT/CT imaging. Methods: The study included 9 patients who underwent myocardial perfusion imaging (MPI). A cardiac phantom with an inserted solid defect was used. The SPECT images were corrected for attenuation using both artifactual CT and CT corrected using metal artifact reduction (MAR). VOI-based analysis was performed in artifactual regions. Results: In phantom studies, mean-of-relative-difference in white-region, between artifact-free attenuation-map without/with MAR were changed from 9.2 and 2.1 to 3.7 and 1.2 for ICD and pacemaker lead, respectively. However, these values for typical patient were 9.7 +/- 7.0 and 3.8 +/- 2.4 for ICD and pacemaker leads respectively, in white-region. MAR effectively reduces the artifacts in white-regions while this reduction is not significant in black-regions. Conclusion: Following application of MAR, visual and quantification analyses revealed that while quality of CT images were significantly improved, the improvements in the SPECT/CT images were not as pronounced or significant. Therefore cardiac SPECT images corrected for attenuation using CT in the presence of metallic-leads can be interpreted without correction for metal artefacts.
引用
收藏
页码:35 / 46
页数:12
相关论文
共 50 条
  • [41] Visualization of infected cardiac pacemaker leads by SPECT in-111 leukocyte imaging
    Squires, S
    Juweid, M
    CLINICAL NUCLEAR MEDICINE, 2005, 30 (08) : 584 - 585
  • [42] Magnetic resonance imaging safety in pacemaker and implantable cardioverter defibrillator patients: how far have we come?
    Nordbeck, Peter
    Ertl, Georg
    Ritter, Oliver
    EUROPEAN HEART JOURNAL, 2015, 36 (24) : 1505 - U81
  • [43] Safety and effectiveness of transvenous extraction of pacemaker and implantable cardioverter-defibrillator leads in patients under or over 80 years of age
    Kempa, Maciej
    Budrejko, Szymon
    Piepiorka, Marta
    Rogowski, Jan
    Raczak, Grzegorz
    Kozlowski, Dariusz
    KARDIOLOGIA POLSKA, 2013, 71 (02) : 130 - 135
  • [44] Transvenous extraction of pacemaker and implantable cardioverter defibrillator leads using Evolution® mechanical dilator sheath: a single center confirmatory experience
    Kocabas, Ugur
    Duygu, Hamza
    Eren, Nihan Kahya
    Akyildiz, Zehra Ilke
    Ozyildirim, Serhan
    Tuluce, Selcen Yakar
    Kiris, Tuncay
    Nazli, Cem
    SPRINGERPLUS, 2016, 5
  • [45] Complete device removal together with reimplantation of a new device is the optimum management of infected pacemaker and implantable cardioverter-defibrillator leads
    Padder, T
    Padder, F
    Kantharia, B
    Panjrath, G
    Ivanov, A
    Albatani, M
    Ahmad, S
    Kutalek, S
    EUROPEAN HEART JOURNAL, 2002, 23 : 665 - 665
  • [46] Effectiveness and Safety of Transvenous Removal of Cardiac Pacing and Implantable Cardioverter-defibrillator Leads in the Real Clinical Scenario
    Costa, Roberto
    da Silva, Katia Regina
    Crevelari, Elizabeth Sartori
    Jurevicius Nascimento, Wagner Tadeu
    Nagumo, Marcia Mitie
    Martinelli Filho, Martino
    Jatene, Fabio Biscegli
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2020, 115 (06) : 1114 - 1124
  • [47] Cardiac chambers perforation by pacemaker and cardioverter-defibrillator leads. Own experience in diagnosis, treatment and preventive methods
    Maziarz, Andrzej
    Zabek, Andrzej
    Malecka, Barbara
    Kutarski, Andrzej
    Lelakowski, Jacek
    KARDIOLOGIA POLSKA, 2012, 70 (05) : 508 - 510
  • [48] THE USE OF CARDIAC MAGNETIC RESONANCE IMAGING TO IDENTIFY CANDIDATES FOR PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    Aznaurov, Sam
    Kusterer, Nathan
    Wilson, Ryan
    Charnigo, Richard
    Leung, Steve
    Elayi, Samy
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A385 - A385
  • [49] Clinical utility of 3-dimensional echocardiography in evaluation of severe tricuspid regurgitation caused by pacemaker or implantable cardioverter-defibrillator leads
    Seo, Yoshihiro
    Ishizu, Tomoko
    Nakajima, Hideki
    Uno, Kiyoko
    Kawamura, Ryou
    Sekiguchi, Yukio
    Watanabe, Shigeyuki
    Yamaguchi, Iwao
    Aonuma, Kazutaka
    CIRCULATION, 2007, 116 (16) : 715 - 715
  • [50] Cost of preimplantation cardiac imaging in patients referred for a primary-prevention implantable cardioverter-defibrillator
    Krahn, Andrew D.
    Hoch, Jeffrey S.
    Rockx, Marie Antoinette
    Leong-Sit, Peter
    Gula, Lorne J.
    Yee, Raymond
    Skanes, Allan C.
    Klein, George J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (05): : 588 - 592